Canada markets close in 3 hours 56 minutes

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.85000.0000 (0.00%)
As of 11:53AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 52.73M
Enterprise Value 18.88M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)31.97
Price/Book (mrq)N/A
Enterprise Value/Revenue 11.67
Enterprise Value/EBITDA -0.67

Trading Information

Stock Price History

Beta (5Y Monthly) 2.16
52-Week Change 3-22.02%
S&P500 52-Week Change 318.92%
52 Week High 31.8500
52 Week Low 30.8250
50-Day Moving Average 31.0040
200-Day Moving Average 31.1533

Share Statistics

Avg Vol (3 month) 3111.89k
Avg Vol (10 day) 377.06k
Shares Outstanding 562.03M
Implied Shares Outstanding 662.03M
Float 854M
% Held by Insiders 17.20%
% Held by Institutions 127.28%
Shares Short (Aug 30, 2023) 4263.44k
Short Ratio (Aug 30, 2023) 42.24
Short % of Float (Aug 30, 2023) 40.46%
Short % of Shares Outstanding (Aug 30, 2023) 40.42%
Shares Short (prior month Jul 30, 2023) 4265.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Jun 29, 2023


Profit Margin 0.00%
Operating Margin (ttm)-1,833.68%

Management Effectiveness

Return on Assets (ttm)-53.03%
Return on Equity (ttm)-353.89%

Income Statement

Revenue (ttm)1.62M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)165.10%
Gross Profit (ttm)1.12M
EBITDA -29.58M
Net Income Avi to Common (ttm)-35.88M
Diluted EPS (ttm)-0.6100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)35.01M
Total Cash Per Share (mrq)0.56
Total Debt (mrq)1.16M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.85
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-24.35M
Levered Free Cash Flow (ttm)-20.56M